Lung Cancer Clinical Trials 2024

Lung Cancer Clinical Trials 2024

Lung Cancer research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in lung cancer clinical trials today.

Lung Cancer Clinical Trials

Here are the 6 most popular medical studies for lung cancer

Popular filter options for lung cancer trials

NSCLC Clinical Trials

View 66 NSCLC medical studies.

Non-Small Cell Lung Cancer Clinical Trials

View 64 Non-Small Cell Lung Cancer medical studies.

Metastatic Lung Cancer Clinical Trials

View 74 metastatic lung cancer medical studies.

EGFR Positive Clinical Trials

View 11 EGFR positive medical studies.

PD-L1 Positive Clinical Trials

View 7 PD-L1 positive medical studies.

Phase 3 Lung Cancer Clinical Trials

View 74 phase 3 lung cancer medical studies.

Lung Cancer Clinical Trials With No Placebo

View 74 lung cancer medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to lung cancer

What are the top hospitals conducting lung cancer research?

In the battle against lung cancer, several hospitals have emerged as leaders in conducting groundbreaking clinical trials. One such institution is the University of California Davis Comprehensive Cancer Center, located in Sacramento. With seven active trials dedicated to lung cancer and an impressive history of 62 completed studies, this center has been making strides in understanding and treating this devastating disease since recording its first trial in 2006.

Another prominent player on the West Coast is UC San Diego Moores Cancer Center in La Jolla. This esteemed facility currently has six active lung cancer trials underway and has contributed to a total of 45 studies over time. Their commitment to advancing knowledge about lung cancer began with their inaugural study recorded in 2009.

Moving further north to Roseville, Sutter Roseville Medical Center demonstrates its dedication by offering five ongoing clinical trials for lung cancer patients while boasting a respectable record of 31 previously conducted investigations since initiating their first trial back in 2004.

The impact of clinical research extends even into smaller communities like Auburn and Cameron Park thanks to Sutter Cancer Centers Radiation Oncology Services-Auburn and Sutter Cancer Centers Radiation Oncology Services-Cameron Park respectively. Both locations are actively involved with five current lung cancer trials each, contributing significantly towards expanding our understanding of this disease through their combined tally of eighteen previous investigations dating back to their first recorded trial also occurring simultaneously ten years ago -in the year 2008.

These top hospitals across California serve as beacons of hope for individuals facing the challenges posed by lung cancer. Through relentless research efforts and participation in clinical trials, they strive not only for breakthrough treatments but also for improved outcomes and quality of life for patients affected by this condition nationwide.

Which are the best cities for lung cancer clinical trials?

When it comes to lung cancer clinical trials, several cities stand out as leaders in research and development. Sacramento, California leads the way with 29 active trials investigating treatments like Crizotinib and High Radiation Dose Therapy. Anchorage, Alaska closely follows with 25 ongoing studies focusing on innovative approaches such as High Radiation Dose Therapy and Crizotinib. Los Angeles, California also makes a significant contribution with 23 active trials exploring various treatment options including Subprotocol C2 (MET exon 14 deletion/mutation) and Cediranib Maleate. These cities offer individuals battling lung cancer access to cutting-edge clinical trials that may lead to improved outcomes in their fight against this disease.

Which are the top treatments for lung cancer being explored in clinical trials?

Lung cancer research is making strides, with several promising treatments being explored in clinical trials. Leading the pack is pembrolizumab, a drug currently involved in six active trials for lung cancer. Since its first listing in 2011, it has already been part of an impressive 190 all-time lung cancer trials. Close behind is nivolumab, also showing potential with four ongoing lung cancer studies and a total of 131 all-time trials since its introduction in 2011. Another contender worth mentioning is atezolizumab, currently being investigated in two active lung cancer trials and boasting 81 all-time clinical trials since its debut in 2013. And not to be forgotten is paclitaxel—a veteran of the field—participating in two ongoing lung cancer studies and accumulating an impressive resume of 189 all-time clinical trials since it was first listed back in 2002. These advancements bring hope for improved outcomes among patients battling this challenging disease.

What are the most recent clinical trials for lung cancer?

Recent clinical trials offer hope and potential advancements in the treatment of lung cancer. One such trial focuses on brigimadlin (BI 907828), exploring its effectiveness as a treatment option for lung cancer patients. Additionally, sitravatinib is being evaluated in a Phase 2 trial to assess its impact on lung cancer. Another study investigates the therapeutic potential of BLU-945 in both Phase 1 and Phase 2 trials for individuals with lung cancer. Furthermore, the combination of pembrolizumab and vibostolimab is being studied extensively in a Phase 3 trial, providing insight into their efficacy against this disease. Lastly, thoracic radiotherapy's role as a treatment modality continues to be explored through a Phase 3 trial aimed at optimizing patient outcomes. These ongoing clinical investigations hold promise for improved therapies in tackling the challenges posed by lung cancer.

What lung cancer clinical trials were recently completed?

Several recent clinical trials have made significant strides in advancing lung cancer research. In May 2022, Vergent Bioscience completed a trial investigating the potential of VGT-309 for treating this complex disease. Additionally, Erasca concluded their ERAS-007 trial in September 2021, while Mirati Therapeutics Inc.'s MRTX849 study reached completion in August 2021. Other important trials include Ociperlimab by BeiGene and Probiotic by Mayo Clinic, both finished in July 2021. These trials highlight the dedication of researchers towards finding innovative treatments and improving outcomes for individuals affected by lung cancer.